FDA
- Application: ANDA080935
- Marketing authorisation holder: NOVARTIS
- Local brand name: INH
- Indication: TABLET — ORAL
- Status: approved
Isoniazid Oral Product (Isoniazid Oral Product) regulatory status in United States.
Yes. FDA has authorised it.
NOVARTIS holds the US marketing authorisation.